Article
Therapeutic Potential of Targeting PAK Signaling
2 Nov 2015
Abstract excerpt
The therapeutic potential of targeting p21-Activated Kinases (PAK1 - 6) for the treatment of cancer has recently gained traction in the biotech industry. Many pharmaceutically-viable ATP competitive inhibitors have been through different stages of pre-clinical development with only a single compound evaluated in human trails (PF-3758309). The best studied functional roles of PAK proteins are control of cell...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
